Skip to main content
Livermore
Livermore
ZHEN

Accelerate Diagnostics, Inc

AXDXDelisted Jul 21, 2025
Industry
Laboratory Analytical Instruments
SEC CIK
0000727207

Accelerate Diagnostics, Inc was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Apr 7, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $3.10M in total; no superinvestor held it.

Holders of 5% or more of AXDX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Accelerate Diagnostics, Inc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of AXDX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Indaba Capital Management, L.P.13D/A9.90%2.75M shares–Feb 6, 20251 filingFeb 6, 2025SEC
Armistice Capital, LLC13G/A7.45%1.88M shares−0.80 ppfrom 8.25%Feb 14, 20252 filingsMay 15, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Accelerate Diagnostics, Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on AXDX
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 15, 20253:23 PM ETArmistice Capital, LLCand 1 other13G/A7.45%1.88M shares−0.80 ppfrom 8.25%Mar 31, 2025SEC
Feb 14, 20254:50 PM ETArmistice Capital, LLCand 1 other13G/A8.25%2.08M shares–Dec 31, 2024SEC
Feb 6, 20253:10 PM ETIndaba Capital Management, L.P.and 2 others13D/A9.90%2.75M shares–Feb 4, 2025SEC
Jan 7, 20254:22 PM ETGriffin Asset Management, Inc.13G/A4.00%1.00M shares–Below 5%Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Accelerate Diagnostics, Inc shares.

No Form 144 notices for Accelerate Diagnostics, Inc are on file.